File #: 21-0827    Name: Proposed Opioids Settlements
Type: Resolution Status: Approved
In control: City Council Regular Meeting
On agenda: 9/21/2021 Final action: 9/21/2021
Title: Consider/Discuss/Act on a Resolution Authorizing the City of McKinney to Participate in the Proposed Opioids Settlements Brought by the State of Texas and Other Jurisdictions Against Various Pharmaceutical Companies for their Roles in the National Opioid Crisis, and Authorizing the City Manager to Execute Documents Related Thereto
Attachments: 1. Resolution, 2. Settlement Allocation Term Sheet, 3. Subdivision Settlement Participation Form
Title
Consider/Discuss/Act on a Resolution Authorizing the City of McKinney to Participate in the Proposed Opioids Settlements Brought by the State of Texas and Other Jurisdictions Against Various Pharmaceutical Companies for their Roles in the National Opioid Crisis, and Authorizing the City Manager to Execute Documents Related Thereto

Summary

COUNCIL GOAL: Operational Excellence

MEETING DATE: September 21, 2021

DEPARTMENT: City Manager's Office

CONTACT: Paul G. Grimes, City Manager


RECOMMENDED CITY COUNCIL ACTION: Staff recommends approval of a resolution authorizing the City of McKinney to participate in the proposed opioids settlements brought by the state of Texas and other jurisdictions against various pharmaceutical companies for their roles in the national opioid crisis and authorize the City Manager to execute documents related thereto.

ITEM SUMMARY: The amount estimated by the Attorney General's Office to be paid to the City is $450,383.00, paid over an 18-year period, with the majority of proceeds to be received in the first several years of that period. The attached resolution expresses the City's intent to participate in the settlements and to accept the settlement terms. Upon adoption, the resolution will be forwarded to the Attorney General's Office.

BACKGROUND INFORMATION: The State of Texas, through the Attorney General's Office, along with a broad coalition of states and political subdivisions from across the country, sued three major opioid distributors, McKesson, Cardinal Health and Amerisource Bergen, along with an opioid manufacturer, Johnson & Johnson, for their role in the national opioid crisis. The purpose of the litigation was for governmental entities to recover costs incurred in combatting opioid use, including drug rehabilitation and treatment costs, hospitalization costs, and law enforcement costs, among others.
As a result of the litigation, all three opioid distributors and opioid manufacturer Johnson & Johnson re...

Click here for full text